Quest 10 Wealth Builders’s Veradermics Inc MANE Stock Holding History

Quest 10 Wealth Builders’s Portfolio MANE Stock Details MANE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$849	Buy	+7	New	+$765	﹤0.01%	742

Other funds holding MANE

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Quest 10 Wealth Builders's MANE Position: Q3 2026 in Review

Quest 10 Wealth Builders opened a new position in Veradermics Inc (MANE) in Q3 2026: 7 shares worth $849. The stake represents ﹤0.01% of the portfolio and ranks #742 among its holdings.

65 funds tracked by Wall St. Rank hold MANE as of Q3 2026.

Quest 10 Wealth Builders held 7 shares of Veradermics Inc worth $849 as of Q3 2026.
Veradermics Inc was a new Quest 10 Wealth Builders position in Q3 2026.
Veradermics Inc made up ﹤0.01% of Quest 10 Wealth Builders's portfolio in Q3 2026, its #742 holding.
65 funds tracked by Wall St. Rank held Veradermics Inc as of Q3 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q3 2026, filed 2 Nov 2026.